Insmed | INSM - Attività Correnti





Attività Correnti Cambiamento Data
BioMarin Pharmaceutical USD 3.97B 633.45M 2026-06
Cytokinetics USD 1.21B 369.02M 2026-06
DBV Technologies USD 189.6M 12.3M 2026-09
Gilead Sciences USD 16.55B 4.02B 2026-09
Heron Therapeutics USD 229.84M 861K 2026-06
Insmed USD 1.71B 72.59M 2026-09
Novartis USD 26.61B 3.85B 2026-03
Regeneron Pharmaceuticals USD 20.8B 2.35B 2026-09
Sarepta Therapeutics USD 2.22B 86.05M 2026-06
Ultragenyx Pharmaceutical USD 606M 51M 2026-06
Vertex Pharmaceuticals USD 12.54B 813.4M 2026-06